Lv75
5010 积分 2020-10-19 加入
S04-03 Sponsor Perspectives on Implementing WOE Approaches
21天前
已关闭
Incidence of Spontaneous and Urethane-Induced Tumors in a 26-Week Carcinogenicity Study in Tg.rasH2 Mice Sourced From CLEA, Japan
23天前
已完结
Human Relevance of Pharmaceutical Drug‐Induced Thyroid Tumors in Rats, Labeling Implications, and Carcinogenicity Study Requirements
23天前
已完结
Carcinogenicity of nitrosoazetidine and tetradeuteronitrosoazetidine in sprague-dawley rats
2个月前
已完结
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial
3个月前
已完结
POS0230 DISAGREEMENT BETWEEN PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OVER TIME IN PSORIATIC ARTHRITIS: INSIGHT INTO TREATMENT PRIORITIES
3个月前
已完结
Species similarities and differences in pharmacokinetics
3个月前
已完结
Pediatric Physiologically Based Pharmacokinetic Models Mediated by Drug-Metabolizing Enzymes: Predictions, Applications, and Challenges
3个月前
已关闭
Prediction of Pharmacokinetic Alterations Caused by Drug-Drug Interactions: Metabolic Interaction in the Liver
3个月前
已完结
The changing landscape of medicinal chemistry optimization
3个月前
已完结
皖公网安备34019202002308
